Bi-specific antibodies and uses thereof
Updated time: 2022-11-15 09:54:42
Bi-specific antibodies and uses thereof
Abstract
Bispecific antibodies have been developed that can simultaneously bind to polyethylene glycol (PEG) and tumor antigens. These antibodies can facilitate delivery, retention and cellular uptake of stealth (PEGylated) liposomes and nanoparticles to target cells and organs.
Technological Advantages
- Does not require haptenization or other modifications of existing nanoparticles and liposomes to increase targeting specificity.
- Bispecific antibodies can join two mainstreams of cancer treatment (clinical targeted antibodies and different PEGylated drugs) to achieve synergistic anticancer efficacy.
- A range of targeting specificities can be conferred by changing the targeting arm of the bispecific antibody
- Pretargeting approaches can be used to maintain maximal nanoparticle stealth properties.
- Bispecific antibodies (clinical antibodies × humanized anti-polyethylene glycol) retain the original anticancer efficacy and can actively attract PEGylated drugs at tumor sites to generate double-attack cancer therapy.
- Intact bispecific antibodies may allow multiple modes of antitumor activity including targeted delivery of nanomedicines, blocking receptor function and induction of immune responses such as antibody-dependent cellular cytotoxicity and complement activation.
- The humanized bispecific-antibodies meet FDA's standard for clinical use.
Docket Number
12A-1020225、12A-1020910、12A-1020225-B
IP Status
TW I560201、JP 6447887、KR 101971770、EP 3126398、SG 11201606791Y、US 11,369,690 B2、US 11,040,111 B2、CN ZL202010087831.2、IL pending
Applications of Technology
- Second generation of Antibody drugs
- Targeted drug delivery
- Nanomedicine
- Cancer targeted therapy
Inventor
Steve Roffler, Tian-Lu Cheng, Yu-Cheng Su, Kuo-Hsiang Chuang, Teresa Tung
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office
Download Files

Bi-specific antibodies and uses thereof